NasdaqCM - Nasdaq Real Time Price USD

Predictive Oncology Inc. (POAI)

1.0700
+0.0600
+(5.94%)
At close: May 8 at 4:00:02 PM EDT
1.0700
0.00
(0.00%)
Pre-Market: 8:00:01 AM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,623.8170
1,623.8170
1,627.6970
1,505.4590
1,420.6800
Cost of Revenue
826.1370
826.1370
609.2120
505.1070
487.0240
Gross Profit
797.6800
797.6800
1,018.4850
1,000.3520
933.6560
Operating Expense
11,737.1500
11,737.1500
13,136.2210
16,268.0670
14,405.2200
Operating Income
-10,939.4700
-10,939.4700
-12,117.7360
-15,267.7150
-13,471.5640
Other Income Expense
79.2650
79.2650
100.1750
-10,469.9190
-6,847.2680
Pretax Income
-10,860.2050
-10,860.2050
-12,017.5610
-25,737.6340
-20,318.8320
Tax Provision
--
--
--
0
-661.6580
Net Income Common Stockholders
-12,664.3880
-12,664.3880
-13,983.9670
-25,737.6340
-19,657.1740
Diluted NI Available to Com Stockholders
-12,664.3880
-12,664.3880
-13,983.9670
-25,737.6340
-19,657.1740
Basic EPS
-2.32
--
-3.48
-6.98
-7.20
Diluted EPS
-2.32
--
-3.48
-6.98
-7.20
Basic Average Shares
5,453.6320
--
4,014.8480
3,685.9540
2,743.8020
Diluted Average Shares
5,453.6320
--
4,014.8480
3,685.9540
2,743.8020
Total Operating Income as Reported
-10,939.4700
-10,939.4700
-12,117.7360
-26,033.6520
-20,428.6310
Total Expenses
12,563.2870
12,563.2870
13,745.4330
16,773.1740
14,892.2440
Net Income from Continuing & Discontinued Operation
-12,664.3880
-12,664.3880
-13,983.9670
-25,737.6340
-19,657.1740
Normalized Income
-10,861.5810
-10,861.5810
-12,030.0180
-15,087.3440
-13,086.1876
EBIT
-10,939.4700
-10,939.4700
-12,117.7360
-15,267.7150
-13,471.5640
EBITDA
-10,243.8070
-10,243.8070
-11,392.9280
-13,954.6400
-12,131.2630
Reconciled Cost of Revenue
826.1370
826.1370
609.2120
505.1070
487.0240
Reconciled Depreciation
695.6630
695.6630
724.8080
1,313.0750
1,340.3010
Net Income from Continuing Operation Net Minority Interest
-10,860.2050
-10,860.2050
-12,017.5610
-25,737.6340
-19,657.1740
Total Unusual Items Excluding Goodwill
1.3760
1.3760
12.4570
-10,650.2900
-6,792.1650
Total Unusual Items
1.3760
1.3760
12.4570
-10,650.2900
-6,792.1650
Normalized EBITDA
-10,245.1830
-10,245.1830
-11,405.3850
-3,304.3500
-5,339.0980
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-221.1786
12/31/2021 - 5/3/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers